|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| (Gain) loss on sale and other income from loans held for sale, net | |||||
| Unrealized fair value changes on loans, related obligations, and derivatives | |||||
| Change in fair value of mortgage servicing rights (“MSR”) | |||||
| Change in fair value of loans and related obligations | |||||
| Amortization and depreciation | |||||
| Impairment of ROU asset | |||||
| Change in fair value of nonrecourse MSR financing liability | |||||
| Impairment of intangibles and other assets | |||||
| Loss on investments | |||||
| Amortization of debt discount and issuance costs on notes payable | |||||
| Impairment of other assets | |||||
| Deferred income taxes | |||||
| Change in fair value of deferred purchase price liabilities | |||||
| Change in fair value of convertible notes | |||||
| Class A Common Stock | |||||
| Total change in fair value of convertible notes | |||||
| Equity-based compensation | |||||
| Non-cash lease expense | |||||
| Provision for claims | |||||
| Originations/purchases of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Change in fair value of warrant liability | |||||
| Gain on the exchange of senior notes | |||||
| Changes in operating assets and liabilities: | |||||
| Other assets, net | |||||
| Payables and accrued expenses | |||||
| Other operating activities, net | |||||
| Net cash used in operating activities | |||||
| Investing Activities | |||||
| Purchases and originations of loans held for investment | |||||
| Proceeds/payments received on loans held for investment | |||||
| Purchases and originations of loans held for investment, subject to nonrecourse debt | |||||
| Proceeds/payments on loans held for investment, subject to nonrecourse debt | |||||
| Proceeds on sale of mortgage servicing rights (“MSR”) | |||||
| Acquisition of American Advisors Group net assets | |||||
| Proceeds from sale of businesses | |||||
| Issuance of notes receivable | |||||
| Other investing activities, net | |||||
| Net cash provided by investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of HMBS related obligations | |||||
| Payments on HMBS related obligations | |||||
| Proceeds from issuance of nonrecourse debt | |||||
| Payments on nonrecourse debt | |||||
| Proceeds from other financing lines of credit | |||||
| Payments on other financing lines of credit | |||||
| Proceeds from notes payable | |||||
| Issuance of Class A Common Stock | |||||
| Payments on notes payable | |||||
| Repurchase of Class A Common Stock and Class A LLC Units | |||||
| Proceeds from issuance of Preferred Stock, net of issuance costs | |||||
| Dividends paid on Preferred Stock | |||||
| Other financing activities, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplementary Cash Flows Information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Loans transferred to loans held for sale, at fair value, from loans held for investment, subject to nonrecourse debt, at fair value | |||||
| Loans transferred to loans held for sale, at fair value, from loans held for investment, at fair value | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...